Damora Therapeutics raises target price to $60 from $40
DMRA•Guggenheim raised its target price for Damora Therapeutics to $60 from $40.
Related News
Allies unite behind Saudi Arabia as Houthis step up attacks
USO•
Wood River Capital disposes of 12,280,426 Aspen Aerogels shares for $58.09 million
ASPN•
Nasdaq halts RPGL trading pending news at 7:50 p.m.
RPGL•
Workday 10% owner David A. Duffield disposes of $19.08 million in common shares
WDAY•
ULVAC to present poster on aluminum nitride thin-film heat spreader process at ADMETA2026
SOXX•